NO20044523L - Planteekstrakter og anvendelse derav - Google Patents

Planteekstrakter og anvendelse derav

Info

Publication number
NO20044523L
NO20044523L NO20044523A NO20044523A NO20044523L NO 20044523 L NO20044523 L NO 20044523L NO 20044523 A NO20044523 A NO 20044523A NO 20044523 A NO20044523 A NO 20044523A NO 20044523 L NO20044523 L NO 20044523L
Authority
NO
Norway
Prior art keywords
schizophrenia
plant extracts
plants
treatment
relates
Prior art date
Application number
NO20044523A
Other languages
English (en)
Inventor
Thomas Haffner
Michael Ploch
Harald Murck
Original Assignee
Lichtwer Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lichtwer Pharma Gmbh filed Critical Lichtwer Pharma Gmbh
Publication of NO20044523L publication Critical patent/NO20044523L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
  • External Artificial Organs (AREA)

Abstract

SAMMENDRAG Oppfinnelsen angår den nye anvendelsen av planter og planteekstrakter for behandling av schizofreni. Slike planter og planteekstrakter er valgt fra perikum, gingko, safran og ginseng. Anvendelsen av substansene skjer fortrinnsvis i forbindelse med vanlige psykoterapeutiske legemidler, dvs. i formen av et preparat som kombinerer standard medikamenter for behandling av schizofreni for den samtidige, separate eller graderte anvendelsen i tilfelle av schizofreni. Oppfinnelsen angår også fremgangsmåter for behandling av schizofreni.
NO20044523A 2002-03-26 2004-10-21 Planteekstrakter og anvendelse derav NO20044523L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10213571A DE10213571A1 (de) 2002-03-26 2002-03-26 Pflanzenextrakte und deren Anwendung
PCT/EP2003/003097 WO2003080085A1 (de) 2002-03-26 2003-03-25 Pflanzenextrakte und deren anwendung

Publications (1)

Publication Number Publication Date
NO20044523L true NO20044523L (no) 2004-12-27

Family

ID=28050879

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044523A NO20044523L (no) 2002-03-26 2004-10-21 Planteekstrakter og anvendelse derav

Country Status (14)

Country Link
US (1) US20050208156A1 (no)
EP (1) EP1487468B1 (no)
JP (1) JP2005527540A (no)
KR (1) KR100804638B1 (no)
AT (1) ATE327763T1 (no)
AU (1) AU2003216884A1 (no)
CY (1) CY1106439T1 (no)
DE (2) DE10213571A1 (no)
DK (1) DK1487468T3 (no)
ES (1) ES2265566T3 (no)
NO (1) NO20044523L (no)
PL (1) PL372396A1 (no)
PT (1) PT1487468E (no)
WO (1) WO2003080085A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4528490B2 (ja) * 2002-06-25 2010-08-18 和光化学株式会社 ギンコライド−ａを含有する抗不安剤
JP4609890B2 (ja) * 2005-10-03 2011-01-12 株式会社常磐植物化学研究所 抗うつ剤
FR2908996A1 (fr) * 2005-11-25 2008-05-30 R & D Pharma Nouveau procede d'extraction de principes actifs et l'utilisation de ceux-ci en therapeutique
FR2908997B1 (fr) * 2005-11-25 2014-03-14 R Et D Pharma Nouvelles compositions therapeutiques et le procede de production des principes actifs
FR2900053B1 (fr) * 2006-04-25 2012-11-16 Cedric Bourges Utilisation du safranal, de la crocine, de la picrocrocine et leurs derives en tant qu'agent de satiete pour le traitement de la surcharge ponderale
JP2010521496A (ja) 2007-03-14 2010-06-24 ノップ ニューロサイエンシーズ、インク． キラル精製置換ベンゾチアゾールジアミンの合成
US20110190356A1 (en) 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
CN103098493A (zh) * 2010-11-12 2013-05-08 松下电器产业株式会社 音压评价系统及其方法、程序
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
PL3019167T3 (pl) 2013-07-12 2021-06-14 Knopp Biosciences Llc Leczenie podwyższonych poziomów eozynofili i/lub bazofili
EP3038467B1 (en) 2013-08-13 2020-07-29 Knopp Biosciences LLC Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
DK3033081T3 (da) 2013-08-13 2021-05-31 Knopp Biosciences Llc Sammensætninger og fremgangsmåder til behandling af kronisk urticaria
CN104224817B (zh) * 2014-08-29 2017-04-26 浙江大学 人参二醇皂苷组分的抗精神分裂症医药用途
CN105288117A (zh) * 2015-10-22 2016-02-03 李肖 一种治疗精神分裂症的组合物及其制备方法
CN105902511A (zh) * 2016-06-01 2016-08-31 汇美农业科技有限公司 一种藏红花素泡腾片及其制备方法
EP3697389B1 (en) * 2017-10-16 2025-08-20 Council of Scientific and Industrial Research Sustained release formulations of crocus sativus
IT201800004108A1 (it) 2018-03-29 2019-09-29 Nathura S P A Composizione a base naturale per l’uso nel trattamento dello stress cronico caratterizzato da disturbi dell’umore e/o ansia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE4239959A1 (de) * 1992-11-27 1994-06-01 Schwabe Willmar Gmbh & Co Johanniskraut-Trockenextrakt, Verfahren zu seiner Herstellung und seine Verwendung
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
ES2162520T3 (es) * 1998-02-13 2001-12-16 Schwabe Willmar Gmbh & Co Medicamentos basados en hiperforina y/o extractos de hiperforina.
IT1301678B1 (it) * 1998-06-10 2000-07-07 Indena Spa Estratti di hypericum perforatum e formulazioni che li contengono.
IT1299195B1 (it) * 1998-06-25 2000-02-29 Sigma Tau Healthscience Spa Composizione ad attivita' neuroprotettiva per la prevenzione ed il trattamento delle alterazioni nervose e comportamentali legate a stati
EP1094712A4 (en) * 1998-07-09 2004-09-08 Cv Technologies Inc HYPERICIN AND HYPERICUM EXTRACT: AGENTS THAT BLOCK TYPE C CALCIUM CHANNELS AND THEIR USE AS THERAPEUTIC AGENTS DIRECTED AGAINST TYPE T CALCIUM CHANNEL
KR20000006625A (ko) * 1998-07-20 2000-02-07 묵인희 인삼추출물을 포함하는 치매 치료제
EP1034782A1 (en) * 1999-03-04 2000-09-13 Andrea Singer Treatment of depression by using compounds which elevate the intracellular sodium concentration
AU3008301A (en) * 1999-12-17 2001-06-25 Pharmaton S.A. Combination of ginseng and ginkgo to improve cognitive skills

Also Published As

Publication number Publication date
EP1487468B1 (de) 2006-05-31
JP2005527540A (ja) 2005-09-15
KR20040091782A (ko) 2004-10-28
ES2265566T3 (es) 2007-02-16
DK1487468T3 (da) 2006-09-25
KR100804638B1 (ko) 2008-02-20
ATE327763T1 (de) 2006-06-15
PL372396A1 (en) 2005-07-25
EP1487468A1 (de) 2004-12-22
PT1487468E (pt) 2006-08-31
DE10213571A1 (de) 2003-10-23
DE50303582D1 (de) 2006-07-06
AU2003216884A1 (en) 2003-10-08
CY1106439T1 (el) 2011-10-12
US20050208156A1 (en) 2005-09-22
WO2003080085A1 (de) 2003-10-02

Similar Documents

Publication Publication Date Title
NO20044523L (no) Planteekstrakter og anvendelse derav
Bourin et al. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors
Kolakar et al. Role of mutation breeding in improvement of medicinal and aromatic crops
NO20073665L (no) 2-fenoksy-N-(1,3,4-tiadizol-2-yl) Pyridin-3-aminderivater og beslektede forbindelser som P2Y1 reseptor inhibitorer for behandling av tromboemboliforstyrrelser
NO20084540L (no) Benzoimidazol-2-ylpyrimidiner og -pyraziner som modulatorer av histamin H4-reseptoren
ATE484494T1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
Mehandru et al. Evaluation of aeroponics for clonal propagation of Caralluma edulis, Leptadenia reticulata and Tylophora indica–three threatened medicinal Asclepiads
NO20071343L (no) Substituerte fenylaminotiazoler og anvendelse derav
NO20052591L (no) Pyridopyrolizin og pyridoindolizinderivater
NO992400L (no) Nye substituerte pyrazolderivater
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
NO20082679L (no) Sammensetning og fremgangsmate for a behandle CNS lidelser
DE59706808D1 (de) Verwendung von 7-(2-oxa-5,8-diazabicyclo 4.3.0]non-8-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur herstellung eines arzneimittels zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
NO20082986L (no) Nye, acylisk substituerte furopyrimidinderivater og anvendelse derav for behandling av kardiovaskulaere lidelser
NO20072854L (no) Acylerte nonadepsipeptider anvendt som lysobaktinderivater
Sattayasai et al. Biphasic effects of Morus alba leaves green tea extract on mice in chronic forced swimming model
CN104888400A (zh) 一种基于led脉冲光降解农药的方法
NO20031963D0 (no) Fremgangsmåter og preparater for behandling av sykdommer i öyet
ATE526015T1 (de) Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien
Narod et al. Biological investigations into Antidesma madagascariense Lam.(Euphorbiaceae), Faujasiopsis flexuosa (Lam.) C. Jeffrey (Asteraceae), Toddalia asiatica (L.) Lam. and Vepris lanceolata (Lam.) G. Don (Rutaceae).
HRPK20060416B3 (en) Herbal mixture and an active substance originating thereof, for enhancing immunity and improving medical treatment
Misra et al. Genetic variability, character association and path analysis for economic traits in Bishop's weed (Ammi visnaga (L.)) Lam
Kaur et al. Exploring the potential of in vitro cultures as an aid to the production of secondary metabolites in Medicinal orchids
Lokesh et al. Neuropharmacological exploration of Thuja occidentalis Linn
DE102004032165A1 (de) Verwendung von Pflanzen der Gattung Sideritis zur Vorbeugung und Beeinflussung von Störungen, die mit einer veränderten serotoninergen Neurotransmission verbunden sind

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application